ArticleHealth promotion international2023
Lobbying by omission: what is known and unknown about harmful industry lobbyists in Australia.
Article in Health promotion international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Rethinking revolving door research: a scoping review of methods and datasets used by non-academics to examine the revolving door.Globalization and health · 2026Article
- Facilitators and barriers of implementing sin-tax policies: a scoping review.BMC public health · 2025Article
- An analysis of framing mechanisms used in alcohol industry submissions to an Australian national parliamentary inquiry.Health promotion international · 2025Article
- Lobbying in the Shadows: A Comparative Analysis of Government Lobbyist Registers.The Milbank quarterly · 2025Article
- An analysis of submissions on regulations to implement Aotearoa New Zealand's tobacco endgame policies.Health promotion international · 2025Article
- Mapping corporate sponsorship of alcohol and gambling associations: An Australian pilot study.Addiction (Abingdon, England) · 2025Article
- Assessing alcohol industry penetration and government safeguards: the International Alcohol Control Study.BMJ global health · 2024Article
- "Games being played": a US exploration of market strategies used by the beverage industry as experienced by food retailers.Globalization and health · 2024Article
- Lobbying in the Sunlight: A Scoping Review of Frameworks to Measure the Accessibility of Lobbying Disclosures.International journal of health policy and management · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
What is unknown about commercial lobbying is far greater than what is known. These omissions distort our understanding of the extent and nature of business influence on politics. Especially when businesses engage in practices that harm health, it is crucial for public health advocates to understand corporate lobbying to counter its influence. Our study proceeded in three phases. First, based on an international audit, we developed a list of the categories of information about lobbying that could be disclosed under four groups (lobby firms, lobbyists, organizations and activities) and benchmarked Australian lobbyist registers against this list. Second, we manually extracted data from lobbyist registers in eight jurisdictions, cleaned the data and created a relational model for analysis. Finally, we classified a sample of organizations as public health organizations or harmful industries to compare their activities. We identified 61 possible categories of information about lobbying in international lobbyist registers. When applied to Australian lobbyist registers, Queensland covered the widest range of categories (13, 21%), though many lacked detail and completeness. Australian lobbyist registers provided data on 462 third-party lobby firms across Australia, currently employing 1036 lobbyists and representing 4101 organizations. Several of these represented harmful industries, with gambling interests hiring the most third-party lobby firms. Ultimately, Australian lobbyist registers do not provide enough information to understand the full extent of lobbying activities taking place. Political transparency is important for public health actors to be able to monitor corporate political activity and to protect policy-making from vested interests.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.